Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Novavax Inc (NVV1)

TradeGate
Symbol
Exchange
Currency
NVAXNASDAQUSD
NVV1TradeGateEUR
Currency in EUR
Disclaimer
3.70
+0.02(+0.52%)
Delayed Data

NVV1 Price Commentary

This company won't go bankrupt. Talking rubbish... buy the share at this low price. 10% of your portfolio or more if you ain't bothered about the possibility of potentially going bust... which I think will sky rocket if we have another pandemic.
Hahahahaha
Bankruptcy in 2025
$10 very soon
Bankruptcy soon?
Should be fine in coming months because the need for vaccines will increase!
a company whereby the share price won't go up whenever there is good news but will plunge as soon as there is the slightest no good news
Share price at 52 wks low, cash & cash equiv per share >$15, Nuvaxovid approved in the U.S., UK, EU, Australia, New Zealand, Japan, etc. Worth a buy here?
Hopeless company
That created onenof the best.. if not the best COVID vaccines on the market.. + one of the best flu caccines + contributed to the first ever successfull malaria vaccine.. yeah sounds pretty hopless. Thanks for your insight. 😂
soon 150 double ur profits
👍🏼😂
it's dangerous to short sell now right? What if FDA approval comes in anytime and gap up next day. Then we are screwed?
You should short. Countries are loosing the covid measures and not requiring vaccination.
FDA approval came through, hope you didn't short sell 💀
The bitter end ?
I think not yet
Positive news pushing up.
Should shoot up soon. Its the best vaccine, long shelf life. Just waiting for US approval
why do you say that?Have you read article on Novavax Cash secured puts Option on investing.com
The vaccines age will end soon…
11% of stocks is shorted
god this is going so bad, free falling
Novavax Submits Final Data Packages to U.S. FDA as Prerequisite to Emergency Use Authorization Application Request for COVID-19 Vaccine
Hopeless company
will touch 230 today
nova future dropping again.
What’s happening. Good news drop. R&D director sells. Why not sack him
Sure? is R&D director?
Is the Politico reported legal securities law violation investigation into Novavax for real or a diversion tactic.As private investors we will never know but everything we read and know for certain about Novavax points to a health Company ready to take off.The current lows of down to $120 should be a fantastic buying opportunity. If not then credibility in all stock news reports will be shattered and a potential trigger for a market plunge.
Purity is critical for vaccines
Novavax Reconfirms Confidence in Regulatory Filing Timelines and Manufacturing QualityOct 20, 2021
strong sell now
Why NVAX director sold around 26000 shares?
to take profit. and buy in again at lower price.
Directors cant just buy and sell as they feel like. So they have pre agreed trading plans. Its just tradhy journos writing rubbish articles to sppok investors.. only motive i can see. They ate probdbly in bed with short sellers. What they usually dont make clear is that when they sell stock they also iften purchase options at the same time.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.